Cytochrome P450 epoxygenase CYP2J2 and the risk of coronary artery disease

被引：44
|
作者：
Spiecker, Martin
Liao, James K.
机构：
[1] Brigham & Womens Hosp, Cambridge, MA 02139 USA
[2] St Josef Hosp Bochum, Dept Med 2, D-44791 Bochum, Germany
来源：
TRENDS IN CARDIOVASCULAR MEDICINE | 2006年 / 16卷 / 06期
关键词：
D O I：
10.1016/j.tcm.2006.04.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Cytochrome P450 (CYP) enzyme 2J2, an epoxygenase predominantly expressed in the heart, metabolizes arachidonic acid to biologically active eicosanoids. One of the CYP2J2 products, 11,12-epoxyeicosatrienoic acid, has several vasoprotective effects. A frequent promoter polymorphism of CYP2J2 decreases gene expression and is associated with coronary artery disease. This association supports the vascular protective role of CYP-derived eicosanoids in cardiovascular disease.
引用
收藏
页码：204 / 208
页数：5
相关论文
共 50 条
  • [41] Expression of recombinant cytochrome P450 epoxygenase in rat brain
    Medhora, A
    Okamoto, H
    Narayanan, J
    Zhang, CY
    Niu, XN
    Taheri, MR
    Kraemer, R
    Capdevila, J
    Harder, DR
    EDHF 2000, 2001, : 228 - 238
  • [42] Modeling of cytochrome P450 (Cyt P450, CYP) channels
    Jankowski, Christopher K.
    Chiasson, Julien B.
    Dako, Etienne
    Doucet, Kathy
    Surette, Marc E.
    Andre, Francois
    Delaforge, Marcel
    SPECTROSCOPY-BIOMEDICAL APPLICATIONS, 2011, 25 (02): : 63 - 87
  • [43] Polymorphisms of Cytochrome P450 1A1 (CYP1A1) Gene, Cigarette Smoking and Risk of Coronary Artery Disease
    Yeh, C. C.
    Chu, H. Y.
    Hsu, W. P.
    Kuo, L. T.
    Sung, F. C.
    EPIDEMIOLOGY, 2008, 19 (06) : S225 - S225
  • [44] Cytochrome P450 epoxygenase promotes human cancer metastasis
    Jiang, Jian-Gang
    Ning, Yao-Gui
    Chen, Chen
    Ma, Ding
    Liu, Zhen-Jun
    Yang, Shilin
    Zhou, Jianfeng
    Xiao, Xiao
    Zhang, Xin A.
    Edin, Matthew L.
    Card, Jeffrey W.
    Wang, Jianing
    Zeldin, Darryl C.
    Wang, Dao Wen
    CANCER RESEARCH, 2007, 67 (14) : 6665 - 6674
  • [45] Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics
    Imig, John D.
    PHARMACOLOGY & THERAPEUTICS, 2018, 192 : 1 - 19
  • [46] Characterization of Four New Mouse Cytochrome P450 Enzymes of the CYP2J Subfamily
    Graves, Joan P.
    Edin, Matthew L.
    Bradbury, J. Alyce
    Gruzdev, Artiom
    Cheng, Jennifer
    Lih, Fred B.
    Masinde, Tiwanda A.
    Qu, Wei
    Clayton, Natasha P.
    Morrison, James P.
    Tomer, Kenneth B.
    Zeldin, Darryl C.
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (04) : 763 - 773
  • [47] Cytochrome P450 2C9-CYP2C9
    Van Booven, Derek
    Marsh, Sharon
    McLeod, Howard
    Carrillo, Michelle Whirl
    Sangkuhl, Katrin
    Klein, Teri E.
    Altman, Russ B.
    PHARMACOGENETICS AND GENOMICS, 2010, 20 (04): : 277 - 281
  • [48] Stereoselective Ketamine Metabolism by Genetic Variants of Cytochrome P450 CYP2B6 and Cytochrome P450 Oxidoreductase
    Wang, Pan-Fen
    Neiner, Alicia
    Kharasch, Evan D.
    ANESTHESIOLOGY, 2018, 129 (04) : 756 - 768
  • [49] Stereoselective Bupropion Hydroxylation by Cytochrome P450 CYP2B6 and Cytochrome P450 Oxidoreductase Genetic Variants
    Wang, Pan-Fen
    Neiner, Alicia
    Kharasch, Evan D.
    DRUG METABOLISM AND DISPOSITION, 2020, 48 (06) : 438 - 445
  • [50] CYTOCHROME EPOXYGENASE P450 2J PROMOTE PPAR A -MEDIATED AUTOPHAGY IN OB-/OB- RATS
    Kim, S.
    Chae, J.
    Jung, L.
    Lee, S.
    Lee, S.
    Rhee, S.
    Kim, W.
    Ko, J.
    Lee, J.
    Kim, Y.
    ATHEROSCLEROSIS, 2019, 287 : E121 - E122
12345